Traders should monitor for the actual execution of this sale, as a large affiliate sale by a key pre-IPO investor could signal reduced conviction or portfolio rebalancing. Watch for any subsequent Form 4 filings confirming the transaction and any impact on the stock price, especially given the stock's recent volatility and the historical underperformance of high-score calls on SEPN.
SEPN drugs
SEPN drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 13 $45.14entry
- T+1 · 3mo ago −1.42%α −1.22% · $44.50
- T+5 · 3mo ago −9.64%α −7.67% · $40.79
- T+20 · 2mo ago −14.69%α −12.94% · $38.51
- T+60 · 11d ago +8.22%α +13.69% · $48.85
Price Chart
How similar events traded
Executive Summary
RA Capital Healthcare Fund LP, a major pre-IPO investor in Septerna, filed a Form 144 on August 12, 2026, signaling intent to sell 746,500 shares of common stock, valued at approximately $35.97 million. This represents a significant proposed sale by a large insider affiliate, potentially indicating a desire to monetize a portion of its holdings post-IPO lock-up expiration, though the filing is an advance notice of intent, not a completed sale.
Key Facts
- RA Capital Healthcare Fund LP filed Form 144 to sell 746,500 shares of Septerna common stock.
- The proposed sale value is approximately $35.97 million based on an estimated market price of $48.20 per share.
- The shares were acquired on October 25, 2024, through the IPO settlement, making this a sale of restricted securities by an affiliate.
- The filing date is August 12, 2026, and the sale is intended to be executed through BTIG LLC.
- RA Capital is a significant pre-IPO investor, and this proposed sale represents a substantial portion of its holdings.
Financial Impact
Proposed sale of 746,500 shares valued at ~$35.97 million, representing approximately 1.6% of Septerna's $2.2B market cap.
Risk Factors
- The sale may not be executed; Form 144 is an intent to sell, not a guarantee.
- Large insider selling by a major investor could pressure the stock price if the market interprets it as a lack of confidence.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001178937-26-000042 |
| Document: 0001178937-26-000042-index.html | 0001178937-26-000042 |
| Document: 0001178937-26-000042.txt | 0001178937-26-000042 |
Track record
25 reports on SEPN
6 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +55.96% at T+60 after the Apr 13, 2026 report. 7 of 7 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
- Nov 16, 2026today 144 Neutral 2/10 Entry price pending
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $42.60 Now $42.60 −0.00% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $42.60 Now $42.60 −0.00% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $41.86 Now $42.60 +1.77% settles Nov 19
- Nov 9, 20267d ago Press Release Bearish 5/10 Entry $52.34 Now $42.60 +18.61% settles Nov 17
- Nov 4, 202612d ago 8-K Neutral 3/10 Entry $47.88 to $48.56 Now $42.60 −11.03% ▲ +1.42% +2.33% vs SPY
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $47.88 to $48.56 Now $42.60 −11.03% ▲ +1.42% +2.33% vs SPY
- Sep 10, 20269w ago Press Release Neutral 2/10 Entry $38.51 to $38.69 Now $42.60 +10.62% ▲ +0.47% +0.69% vs SPY
- Sep 3, 202610w ago 3 Neutral 2/10 Entry $36.75 to $39.55 Now $42.60 +15.92% ▲ +7.62% +8.83% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers